Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Ann Surg. 2012 Oct;256(4):573–580. doi: 10.1097/SLA.0b013e31826cbbbd

Table 4.

Summary of Patients Who Underwent Resection

Patient Number Age at Enrollment (days) Structural character Diagnosis of NBL (INSS Stage) Initial Treatment COG Risk Group Reason for Surgery # Days Between Enrollment & Surgery Outcome*
1 32 Cystic Yes (Stage 1) Surgery Low Immediate surgery arm 2 Alive w/o event
2 8 Solid Yes (Stage 1) Observation Only Low >50% increase in volume 421 Alive w/o event
3 40 Cystic No ACN Observation Only NA >50% increase in volume 25 Alive w/o event
4 76 Solid Yes (Stage 1) Observation Only Low >50% increase in volume 12 Lost to follow-up
5 29 Solid No EPS Observation Only NA >50% increase in volume 794 Alive w/o event
6 28 Solid No Hematoma Observation Only NA Elective surgery at parental request 492 Lost to follow-up
7 33 Cystic Yes (Stage 1) Surgery Low Immediate surgery arm 1 Alive w/o event
8 36 Solid Yes (Stage 2B) Observation Only Low >50% increase in volume 58 PD at time of resection; Lost to follow-up
9 27 Cystic Yes (Stage 1) Observation Only Low Elective surgery at parental request 247 Alive w/o event
10 37 Solid Yes (Stage 4S) Observation Only Intermediate Progressive disease or recurrence (Liver nodules) 21 PD at time of resection; Alive
11 135 Solid Yes (Stage 1) Surgery Low Immediate surgery arm 2 Alive w/o event
12 28 Solid No ACN Observation Only NA >50% increase in volume 24 Alive w/o event
13 24 Cystic No Hematoma Observation Only NA Persistent VMA/HVA < 0.5 71 Lost to follow-up
14 185 Solid Yes (Stage 1) Observation Only Low >50% increase in volume 156 Alive w/o event
15 151 Solid Yes (Stage 1) Observation Only Low >50% increase in volume 57 Alive w/o event
16 22 Solid No EPS Observation Only NA Elective surgery at parental request 142 Alive w/o event
17 94 Solid Yes (Stage 1) Observation Only Low >50% increase in volume 86 Alive w/o event
18 50 Solid Yes (Stage 1) Observation Only Low >50% increase in volume 25 Alive w/o event
19 22 Solid Yes (Stage 1) Observation Only Low > 50% increase in VMA or HVA 47 Alive w/o event
20 27 Solid No EPS Surgery NA Immediate surgery arm 2 Alive w/o event
*

Immediate Surgery patients were only required to submit 1 month of follow-up data. (ACN, adrenal cortical neoplasm; EPS, extralobar pulmonary sequestration; PD, progressive disease)